PainResearch Phase

Dynorphin A

Endogenous peptide

Overview

Dynorphin A is an endogenous opioid peptide of 17 amino acids that preferentially binds to and activates kappa-opioid receptors, though it also has affinity for mu and delta receptors at higher concentrations. It is derived from the precursor protein prodynorphin and plays a complex role in pain modulation, stress responses, and dysphoria.

Mechanism of Action

Unlike mu-opioid agonists, kappa receptor activation can produce analgesia without typical euphoria but may induce aversive psychological effects. Dynorphin also has non-opioid actions at high concentrations, including NMDA receptor modulation..

Research Summary & Key Findings

Dynorphin A has been extensively studied in preclinical models to characterize endogenous pain pathways and kappa-opioid receptor function. Elevated dynorphin levels have been associated with chronic pain states and stress-induced hyperalgesia in animal studies. Clinical development of dynorphin itself as a therapeutic has not advanced due to poor stability, blood-brain barrier penetration challenges, and complex receptor pharmacology.

Clinical Status

Research Phase

Dynorphin A is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

Endogenous peptide

Related Peptides in Pain

Find a Provider

Find a verified provider who offers Dynorphin A therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Dynorphin A.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.